Evaluating the use of Monoclonal Antibodies - Sotrovimab, Casirivimab/Imedvimab (REGEN-COV) and Tixagevimab/Cilgavimab (EVUSHELD) for COVID-19 Treatment in Singapore
Chua et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofae631.2172
https://c19early.org/chuar.html